H

Hua Medicine
HKEX:2552

Watchlist Manager
Hua Medicine
HKEX:2552
Watchlist
Price: 1.53 HKD 4.79%
Market Cap: 1.5B HKD
Have any thoughts about
Hua Medicine?
Write Note

Hua Medicine
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hua Medicine
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
H
Hua Medicine
HKEX:2552
Accrued Liabilities
ÂĄ19.4m
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accrued Liabilities
ÂĄ2B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accrued Liabilities
ÂĄ620.1m
CAGR 3-Years
74%
CAGR 5-Years
53%
CAGR 10-Years
31%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accrued Liabilities
ÂĄ128.5m
CAGR 3-Years
456%
CAGR 5-Years
130%
CAGR 10-Years
63%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accrued Liabilities
ÂĄ1.5B
CAGR 3-Years
74%
CAGR 5-Years
54%
CAGR 10-Years
46%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accrued Liabilities
ÂĄ146m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hua Medicine
Glance View

Market Cap
1.5B HKD
Industry
Pharmaceuticals

Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 146 full-time employees. The company went IPO on 2018-09-14. The firm is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The firm mainly operates its business in the domestic and overseas markets.

Intrinsic Value
0.34 HKD
Overvaluation 78%
Intrinsic Value
Price
H

See Also

What is Hua Medicine's Accrued Liabilities?
Accrued Liabilities
19.4m CNY

Based on the financial report for Jun 30, 2024, Hua Medicine's Accrued Liabilities amounts to 19.4m CNY.

What is Hua Medicine's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
3%

Over the last year, the Accrued Liabilities growth was -1%. The average annual Accrued Liabilities growth rates for Hua Medicine have been 1% over the past three years , 3% over the past five years .

Back to Top